Welcome to the RadPro News-Zone newsletter. 
To contribute editorial, news, job vacancies or educational events please email


RadPro 365 Live News-Zone for October 2019

New from RadPro
A “Radiographers life” in Radiotherapy… a monthly Blog by Duncan Hynd
These boots were made for walking…
A look at how we can attract more men to become therapeutic radiographers and how will the NHS’s need for an extra 2000 therapeutic radiographers by 2027 be met?
Pic: Were hard hats required in the 80’s?
Read more

“Innovations in Radiotherapy”
Our leading monthly industry profile of the latest products and services in radiotherapy. 

This month we feature Xstrahl and their new SARRP beamline.

Xstrahl Launches the New SARRP Beamline for Proton, Photon, Carbon and Flash Pre-Clinical Experiments.

Xstrahl Life Science, global leader in the development of advanced X–ray systems for pre-clinical radiation biology research, is launching its latest radiation research platform. The new SARRP beamline system is a fully comprehensive radiation research platform to be used with proton, photon, carbon and flash experiments, offering researchers an unparalleled level of imaging.
Read more


Contact details and Media Enquiries: Rhys Turton,      + 44 7519121910.

 “Tweets of the Month”
We highlight some of the most popular and interesting tweets of the month from our partner companies. 

Click on the tweet to be taken to Twitter

"Question of the month!"

What is FLASH Radiotherapy?
With some of our partner companies regularly promoting FLASH Radiotherapy as a novel research tool and its rapid introduction to main stream radiotherapy parlance and to our attention as radiotherapy practitioners largely this year, we ask what is it and where is it heading? This recent link explains it well.
Read more.

"What we’re watching"

e showcase some selected videos of interest to our readers in radiotherapy and those from our partners

  • Follow the journey of an orthovoltage radiotherapy patient at the Cheltenham General Hospital, UK. Watch here
  • Machine learning is one of the fastest-growing areas of technology today. It has had a key role in advances in many fields, and its significance for the future of healthcare is potentially enormous. Watch here.
  • As we recognize Breast Cancer Awareness Month, Elekta salutes everyone who has been touched by this disease – those currently undergoing treatment, those who are breast cancer survivors and everyone who has helped a friend or loved one navigate their treatment journey. Watch here
  • Flash Radiotherapy. In this video, IntraOp, the leader in electron therapy, demonstrates the first mobile linear accelerator available for preclinical and research testing of FLASH radiation with electrons.  Watch here.

"What We’re Reading"

Curated News feed

  • Xstrahl and Washington DC-based C&C Irradiator Service are announcing a partnership to supply next generation X-ray irradiator systems to replace cesium sources across the U.S.   Used throughout the world, with hundreds in the United States, Cesium-137 is a radioactive source used in equipment such as older generation radiotherapy systems and irradiators. However, it is a potentially dangerous radioactive isotope that is difficult to dispose of safely and responsibly, and its potential use in a terrorist attack also causes concern. Read more.
  • With the rates of skin cancers ever increasing, especially in places with high sun prevalence, treatment of these conditions can cause not only a demand on resources, but there is a lack of unified response and the best way to treat.
    This is why Prof. Gerald Fogarty of GenesisCare in Australia has used the Xstrahl 150 system to treat four cases of skin cancer. The process and results of the treatments have been summarised as case studies, which demonstrate how superficial radiotherapy can be the best choice for these conditions. Read more. 
  • RaySearch has received a new regulatory clearance from the Chinese authorities NMPA (previously CFDA) for the treatment planning system RayStation®.
    With this
    clearance RaySearch can continue to supply the innovative and machine agnostic RayStation to customers in China. With its large population, China puts stringent requirement on speed and efficiency in the treatment process in order to offer advanced radiotherapy treatments to as many patients as possible. This also suits RayStation well, as it has a strong automation focus and can easily be scaled to fit each customer’s needs and requirements. Read more. 
  • RaySearch has signed a contract with the United States Department of Veterans Affairs (VA) to become one of the agency's preferred providers of radiation therapy software to hospitals within the Veterans Health Administration.
    The Veterans Health Administration is America’s largest integrated health care system, serving approximately 9 million veterans each year, of which around 40,000 patients are newly diagnosed cancer patients. The National Acquisition Center (NAC) is responsible for supporting the health care requirements of the VA and other government agencies, awards national contracts and blanket purchase agreements for the acquisition and direct delivery of treatment planning systems (TPS), as well as oncology information systems (OIS). Read more.
  • Today, big data and analytics are changing the way decisions are made – from everyday business challenges to differentiating a company in an effort to gain competitive advantage.
    Rather than relying on historical trends and intuition when maintaining inventory, pricing solutions or hiring employees, companies are embracing data and analytics for faster and more fact-based decision-making. Companies like Hulu and Netflix, for example, work with an abundance of big data daily to analyze user tendencies, trends in consumption and much more
    . Read more. 
  • Elekta announces that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has been awarded the Institute of Physics (IOP) Business Innovation Award 2019.
    The IOP Business Awards are the only awards recognizing companies in the UK and Ireland that have built success on the innovative application of physics. The Award is a tremendous mark of recognition that the recipient company is at the cutting edge of physics and business.
    Read more.

What we’re reading in the Press and International Media, some selected thought-provoking stories:

Installation of state-of-the-art radiation therapy equipment has placed the Royal (Dick) School of Veterinary Studies’ (R[D]SVS) Hospital for Small Animals at the forefront of veterinary cancer treatment in Europe.

The introduction of the Varian Medical Systems VitalBeam linear accelerator is said to herald a new era of radiotherapy to pets in the UK, offering the same cutting-edge radiation treatment options you would find in any human hospital. Read more

Breast cancer death rate falls 44% in almost 30 years

The death rate for women with breast cancer has plunged 44% in nearly 30 years, according to new figures. Analysis by Cancer Research UK suggests that more than 130,000 UK breast cancer deaths have been avoided in the last three decades. Deaths from the disease hit a record high in 1989, when around 15,600 women lost their lives to breast cancer. Read more.

Gut Bacteria “Fingerprint” Can Predict Radiotherapy Side Effects

Taking a “fingerprint” of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study shows. Read more.


Breath-hold technique reduces patient motion during radiotherapy

A new technique to reduce or eliminate breathing-related movement during radiotherapy and diagnostic imaging exams has been developed by researchers at the University Hospitals Birmingham NHS Foundation Trust. Read more.

Prostate cancer patients can now have side effects of radiotherapy reduced, according to surgeon Tim Dudderidge.

A life-changing gel injection, known as SpaceOAR hydrogel, is now being used by Southampton Read more. 
clinicians, and reduces the amount of radiation that can pass through the prostate and damage the rectum during treatment. Read more.

To comment on our news items please go to our @RadProwebsite twitter feed or blog page and for more news use our new radiotherapy news-stream app

For the latest Radiotherapy news use our innovative RadPro LIVE radiotherapy news APP located here and follow instructions to download this to your mobile phone or tablet.

"Did you know?"   

Our section of interesting facts from our partners

Xstrahl, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, has launched new dermatology-specific modules to the Xstrahl Learning Portal. You can sign up here:
Read more

Virtual Exhibition Stand of the month… why not check out the stands of our leading international partner companies. This month it’s Elekta
Click here to visit the virtual stand and exhibition

How to participate in RadPro 365 Live.

If you want to contribute to RadPro 365 live as a delegate and submit papers presentations and posters go here  and click on our chatbot icon.

If you are a commercial company, organisation or service provider involved in radiotherapy contact us on for more information.
Ways to keep in touch with us at RadPro
You can also keep in touch using our Social Media feeds by using Twitter @RadProWebsite or Facebook 

Contact us for more information on joining our innovative RadPro 365 Live event and publishing your news in our e-Lectron newsletter. For non-members there is a fee for this and the costs are mentioned on our website price list.
RadPro is now a trading name of Hynd Healthcare ltd 

Copyright © 2019 Hynd Healthcare, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
RadPro · Claremont House · Deans Court · Bicester, Oxfordshire OX26 6BW · United Kingdom

Email Marketing Powered by Mailchimp